Selecting a Selective Serotonin Reuptake Inhibitor: Clinically Important Distinguishing Features
AUTOR(ES)
Marken, Patricia A.
FONTE
Physicians Postgraduate Press
RESUMO
Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed to treat depression. Although these drugs presumably have the same mechanism of action, they vary in several clinically important ways, including how long they remain in the body and the extent to which they interfere with the metabolism of other medications. This article reviews the pharmacologic differences among SSRIs and how these differences may affect various aspects of treatment, such as dosing, administration, and discontinuation. Understanding the distinct properties of SSRIs may help primary care physicians to design the most appropriate therapeutic plan for individual patients.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=181142Documentos Relacionados
- A concise total synthesis of (R)-fluoxetine, a potent and selective serotonin reuptake inhibitor
- The role of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome
- Dosing of Selective Serotonin Reuptake Inhibitors
- Reduction of intraspecific aggression in adult rats by neonatal treatment with a selective serotonin reuptake inhibitor
- Selective serotonin reuptake inhibitors for fibromyalgia syndrome